Malaria in Pregnancy Clinical Trial
— TIPTOPOfficial title:
Evaluation of Community Delivery of Malaria Intermittent Preventive Treatment in Pregnancy (C-IPTp) (TIPTOP Project)
Verified date | March 2022 |
Source | Jhpiego |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study evaluates the effectiveness of community delivery of sulfadoxine-pyrimetamine (SP) for intermittent preventive treatment of malaria in pregnancy (IPTp) in increasing the coverage of IPTp among pregnant women in selected districts in Democratic Republic of Congo (DRC), Madagascar, Mozambique and Nigeria, compared to comparison districts where SP for IPTp is distributed as usual in facilities through routine antenatal care (ANC).
Status | Completed |
Enrollment | 10602 |
Est. completion date | October 31, 2021 |
Est. primary completion date | October 31, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 15 Years to 49 Years |
Eligibility | Inclusion Criteria: - Women who had a pregnancy that ended in the 12 months preceding the survey - Being resident in the study area during for at least 4 months before the end of the pregnancy - Willing to participate in the household survey (signing informed consent/assent, in line with country guidelines) Exclusion Criteria: - Anyone considered to be a minor in their country. - Not willing to provide informed consent |
Country | Name | City | State |
---|---|---|---|
Congo, The Democratic Republic of the | Bulungu District, Community Setting | Bulungu | Kwilu |
Congo, The Democratic Republic of the | Kenge District, Community Setting | Kenge | Kwango |
Congo, The Democratic Republic of the | Community Setting | Kunda | Maniema |
Madagascar | Mananjary District, Community Setting | Mananjary | Fianarantsoa |
Madagascar | Community Setting | Toliary 2 | Fianarantsoa |
Madagascar | Community Setting | Vohipeno | Vatovavy-Fitovinany |
Mozambique | Meconta District, Community Setting | Meconta | Nampula |
Mozambique | Community Setting | Murrupula | Nampula |
Mozambique | Nhamatanda District, Community Setting | Nhamatanda | Sofala |
Nigeria | Community Setting | Akure South | Ondo |
Nigeria | Community Setting | Bosso | Niger |
Nigeria | Community Setting | Ohaukwu District | Ebonyi |
Lead Sponsor | Collaborator |
---|---|
Jhpiego | Barcelona Institute for Global Health |
Congo, The Democratic Republic of the, Madagascar, Mozambique, Nigeria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | IPTp3 Coverage | Proportion of women who had a pregnancy ending in the past 12 months and have received three or more doses of IPTp-SP | 1 year | |
Secondary | IPTp1 Coverage | Proportion of women who have had a pregnancy that ended in the past 12 months and have received one or more doses of IPTp-SP | 1 year | |
Secondary | ANC 4 coverage | • Proportion of women who have had a pregnancy that ended in the past 12 months and have attended ANC clinics four times | 1 year | |
Secondary | ANC 1 Coverage | Proportion of women who have had a pregnancy that ended in the past 12 months and have attended ANC clinics at least once | 1 year | |
Secondary | Early ANC Coverage | Proportion of pregnant women attending the first ANC visit before or at week 14 | 1 year | |
Secondary | C-IPTp Knowledge | Proportion of women who have had a pregnancy that ended in the past 12 months who know about the IPTp service provided by CHWs | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03508349 -
Routine Antenatal Care Versus Screening and Treatment of Malaria in Pregnancy in Rwanda
|
N/A | |
Completed |
NCT01053325 -
Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy
|
Phase 3 | |
Completed |
NCT00140517 -
Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance
|
N/A | |
Recruiting |
NCT05306067 -
Plasmodium Falciparum Genomic Intelligence in Mozambique
|
||
Recruiting |
NCT05757167 -
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
|
Phase 4 | |
Active, not recruiting |
NCT01555255 -
Malaria Rapid Diagnostic Tests (RDTs) in Pregnancy: Detection of Placental Malaria
|
N/A | |
Completed |
NCT01136850 -
Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea
|
Phase 3 | |
Terminated |
NCT04148690 -
Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania
|
N/A | |
Completed |
NCT04160026 -
Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya
|
Phase 4 | |
Completed |
NCT04783051 -
Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)
|
Phase 3 | |
Not yet recruiting |
NCT05348746 -
ERASE - Impact of COVID-19 on Malaria Control
|
||
Completed |
NCT03998839 -
TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study
|
||
Completed |
NCT03208179 -
Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa
|
Phase 3 | |
Completed |
NCT01120145 -
Assessment of Sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Malawi
|
N/A | |
Completed |
NCT00730366 -
New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa
|
Phase 3 | |
Completed |
NCT00852423 -
Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria
|
Phase 3 | |
Completed |
NCT00680732 -
Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component
|
Phase 4 | |
Recruiting |
NCT03754322 -
LAMP Detection of Malaria in PREGnancy (LAMPREG) Trial
|
N/A | |
Not yet recruiting |
NCT03944317 -
Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP)
|
N/A | |
Completed |
NCT05294406 -
Intermittent Preventive Treatment With Dihydroartemisinin-piperaquine in Papua, Indonesia
|
Phase 4 |